You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Primacor In Dextrose 5% In Plastic Container, and what generic alternatives are available?

Primacor In Dextrose 5% In Plastic Container is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Primacor In Dextrose 5% In Plastic Container

A generic version of PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as milrinone lactate by FRESENIUS KABI USA on May 28th, 2002.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What are the global sales for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mahidol UniversityPhase 2
Zagazig UniversityPhase 4
Vanderbilt University Medical CenterPhase 1

See all PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 020343-001 Aug 9, 1994 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Sanofi Aventis Us PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 020343-004 Aug 9, 1994 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Sanofi Aventis Us PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 020343-002 Aug 9, 1994 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Sanofi Aventis Us PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 020343-003 Aug 9, 1994 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 020343-001 Aug 9, 1994 ⤷  Subscribe ⤷  Subscribe
Sanofi Aventis Us PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 020343-003 Aug 9, 1994 ⤷  Subscribe ⤷  Subscribe
Sanofi Aventis Us PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 020343-002 Aug 9, 1994 ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER

See the table below for patents covering PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER around the world.

Country Patent Number Title Estimated Expiration
Australia 536354 ⤷  Subscribe
Luxembourg 83258 ⤷  Subscribe
Germany 3044568 ⤷  Subscribe
United Kingdom 2065642 5-(PYRIDINYL)-2-(1H)-PYRIDINONES USEFUL AS CARDIOTONIC AGENTS AND THEIR PREPARATION ⤷  Subscribe
United Kingdom 2073185 DIAMINO-PYRIDINES USEFUL AS CHEMICAL INTERMEDIATES AND CARDIOTONICS ⤷  Subscribe
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.